BofA bullish on Dassault as Rafale orders could extend backlog visibility

BofA upgraded Dassault Aviation to Buy from Neutral and lifted its price target to €360 from €345, implying roughly 27% upside from the cited €284 share price. The broker cites a 7.5-year Rafale production backlog, potentially expanding to about 15 years if prospective Indian and Ukrainian orders totaling up to 214 aircraft are secured. BofA views Dassault's roughly 8x 2027 EV/EBIT valuation as inexpensive, though it expects temporary Falcon 10X learning-curve pressure and sees risks from delayed or unrealized Rafale contracts.

Analysis

Dassault’s equity setup is less a near-term earnings revision story than a duration and capital-allocation mispricing: the market appears to value the defense franchise on a conventional cyclical multiple despite unusually long sovereign-program cash-flow visibility. The embedded Thales holding (HO) and net-cash position provide downside ballast, while Falcon creates asymmetric upside if certification execution is merely adequate rather than exceptional. A sustained rerating requires evidence that production-rate expansion can occur without diluting margins or creating supplier bottlenecks across engines, avionics and mission systems.

The key second-order beneficiary of incremental Rafale volumes is Thales, whose radar, electronic warfare and communications content should rise with aircraft deliveries, but HO is likely a cleaner way to express systems-content growth with less exposure to a single airframe decision. Conversely, Safran is a potential indirect beneficiary through M88 engine demand, though its civil-aerospace mix will dilute the signal. The principal risk is that investors capitalize announced sovereign intent well before binding funding, export-credit and delivery terms are finalized; a procurement slippage could compress the defense-duration premium rapidly even if the long-run strategic demand remains intact.

Over the next 1-3 months, Indian budget, procurement-committee and government-to-government process milestones matter more than broker target changes. Over 6-18 months, the decisive variables are annual Rafale delivery cadence, working-capital conversion, and Falcon 10X certification milestones. The bullish thesis is falsified if management cannot support a credible production-rate path, if new order discussions fail to progress into funded negotiations, or if Falcon development costs force a material reduction in medium-term free-cash-flow guidance.

Key Decisions for Investors

• Initiate a 12-18 month long AM position on weakness, sized at 50-75% of a normal defense position because prospective export wins remain non-binding. Target a rerating toward the broker’s implied upside range; cut or reassess on evidence of procurement deferral or a material reduction in production/cash-conversion guidance.
• Use a long AM / long HO basket rather than AM alone for incremental exposure to European combat-air rearmament: AM provides airframe and backlog-duration optionality, while HO captures higher-value mission-system content. Rebalance toward HO if airframe order timing slips but European defense-electronics budgets remain intact.
• Do not use BBD.A as a near-term short hedge for the Falcon valuation gap. The apparent multiple discount is not directly monetizable while Falcon faces a development and certification cost curve; instead, monitor Falcon 10X schedule, order intake and margin commentary before treating the business-jet valuation discount as a catalyst.
• Set event alerts around Indian defense-budget approvals and formal procurement milestones over the next quarter. If these advance without AM rerating, add exposure; if they are deferred beyond the expected decision window, reduce the position before backlog-extension expectations unwind.